The Childhood Cancer Blog
The Childhood Cancer Blog
![Ginny Mclean (center) from the Swifty Foundation togther with Liz and Jay Scott](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/untitled_design-118.png?itok=sNAps8Qc)
Ginny Mclean (center) from the Swifty Foundation togther with Liz and Jay Scott
Patti Gustafson became aware of childhood cancer when her son Michael was diagnosed with medulloblastoma, a type of brain tumor. Michael was nearing the end of his life when he developed his “Master Plan” to donate his tumor tissue to science so a cure might be found for other children. From his plan, the Swifty Foundation was born.
Michael died at the age of 15. Today, his family caries on his foundation.
“Before I was in this space, I always assumed 'somebody' was curing childhood cancer. I mean, everyone wants children to stop dying from cancer, so of course it’s... Read More
![12-year neuroblastoma survivor Lucy. lucy littlefield](https://www.alexslemonade.org/sites/default/files/styles/blog_full/public/untitled_design-117.png?itok=2ByiU3Lh)
12-year neuroblastoma survivor Lucy.
Dr. Janice Withycombe, an ALSF-funded research nurse at Clemson University and Prisma Health, believes that the long-term side effects of pediatric cancer treatment can best be understood not by talking to the parents of a child, but by talking to the child directly to hear their experience.
Childhood cancer treatments — especially chemotherapy, radiation and surgery — come with a myriad of immediate, short-term and lifelong side effects. Side effects during treatment can make the harsh months of... Read More
Chemotherapy has long been a part of the frontline treatment plan for kids battling high-risk neuroblastoma. But when neuroblastoma becomes chemotherapy resistant, doctors are left with a dwindling list of options for children, who are desperate for cures.
For these children, it is critical that researchers work to understand what causes this chemotherapy resistance and then find a therapy that works. One Alex’s Lemonade Stand Foundation (ALSF) researcher, Dr. Patrick Reynolds, made a discovery that could be a game changer.
Using cancer tumor models and cell lines... Read More
Pages